Editorial: Heterogeneity in breast cancer: clinical and therapeutic implications

被引:2
|
作者
Carlino, Francesca [1 ]
Solinas, Cinzia [2 ]
Orditura, Michele [3 ]
Bisceglia, Maria Dezia [4 ]
Pellegrino, Benedetta [5 ]
Diana, Anna [6 ]
机构
[1] Osped Ave Gratia Plena, Med Oncol Unit, San Felice A Cancello, Caserta, Italy
[2] Azienda Osped Univ AOU Cagliari Policlin Duilio Ca, Azienda Osped Univ AOU Cagliari Policlin Duilio Ca, Cagliari, Italy
[3] Med Oncol Unit, Aienda Osped Rilievo Nazl AORN St Anna & San Sebas, Caserta, Italy
[4] Aienda Osped Rilievo Nazl AORN St Anna & San Sebas, Aienda Ospedaliera Rilievo Nazl A O R N St Anna &, Caserta, Italy
[5] Univ Hosp Parma, Med Oncol & Breast Unit, Parma, Italy
[6] Osped Mare, Med Oncol Unit, Naples, Italy
来源
FRONTIERS IN ONCOLOGY | 2024年 / 14卷
关键词
breast cancer; heterogeneity; molecular mechanisms; drug resistance; emerging technologies;
D O I
10.3389/fonc.2024.1321654
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:5
相关论文
共 50 条
  • [31] Editorial: Monoclonal gammopathies of clinical significance: Clinical and therapeutic implications
    Wang, Chen
    Xu, Chuanhui
    Li, Jian
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [32] Dynamic Cancer Cell Heterogeneity: Diagnostic and Therapeutic Implications
    Jacquemin, Valerie
    Antoine, Mathieu
    Dom, Genevieve
    Detours, Vincent
    Maenhaut, Carine
    Dumont, Jacques E.
    CANCERS, 2022, 14 (02)
  • [33] Heterogeneity of driver genes and therapeutic implications in colorectal cancer
    Dienstmann, R.
    Cervantes, A.
    ANNALS OF ONCOLOGY, 2015, 26 (08) : 1523 - 1525
  • [34] Chemokines in triple-negative breast cancer heterogeneity: New challenges for clinical implications
    Mehraj, Umar
    Mushtaq, Umar
    Mir, Manzoor A.
    Saleem, Afnan
    Macha, Muzafar A.
    Lone, Mohammad Nadeem
    Hamid, Abid
    Zargar, Mohammed A.
    Ahmad, Syed Mudasir
    Wani, Nissar Ahmad
    SEMINARS IN CANCER BIOLOGY, 2022, 86 : 769 - 783
  • [35] Deconstructing Breast Cancer Heterogeneity: Clinical Implications for Women With Basal-Like Tumors
    Rattani, Nabila S.
    Swift-Scanlan, Theresa
    ONCOLOGY NURSING FORUM, 2014, 41 (06) : 639 - 646
  • [36] AROMATASE INHIBITORS - CLINICAL-PHARMACOLOGY AND THERAPEUTIC IMPLICATIONS IN BREAST-CANCER
    PEREZ, N
    BORJA, J
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1992, 20 (04) : 303 - 312
  • [37] Molecular heterogeneity and MYC dysregulation in triple-negative breast cancer: genomic advances and therapeutic implications
    Priya, Arun
    Kumar, Arun
    Kumar, Dhruv
    3 BIOTECH, 2025, 15 (01)
  • [38] GENOMIC HETEROGENEITY IN GLIOBLASTOMA: AN OVERVIEW OF ITS CLINICAL AND THERAPEUTIC IMPLICATIONS
    Jhanwar, Suresh C.
    ANTICANCER RESEARCH, 2014, 34 (10) : 5977 - 5978
  • [39] Clinical and therapeutic implications of BRAF mutation heterogeneity in metastatic melanoma
    Ardakani, Nima Mesbah
    Leslie, Connull
    Grieu-Iacopetta, Fabienne
    Lam, Wei-Sen
    Budgeon, Charley
    Millward, Michael
    Amanuel, Benhur
    PIGMENT CELL & MELANOMA RESEARCH, 2017, 30 (02) : 233 - 242
  • [40] The clinical heterogeneity of Parkinson's disease and its therapeutic implications
    Greenland, Julia C.
    Williams-Gray, Caroline H.
    Barker, Roger A.
    EUROPEAN JOURNAL OF NEUROSCIENCE, 2019, 49 (03) : 328 - 338